Dr. Ali Abuhaleima

Dr. Ali Abuhaliema is an Assistant Professor in the School of Applied Medical Sciences at the German Jordanian University (GJU). He received his doctorate (Dr. rer. nat.) in Pharmaceutical Sciences as a DAAD scholar at Saarland University and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Germany. His doctoral research identified the first small-molecule inhibitors of the oncogenic RNA-binding protein IGF2BP2/IMP2. He also holds an MSc in Clinical Pharmacy from the University of Jordan, completed with a DAAD scholarship, and a BSc in Pharmacy from Al-Azhar University, Gaza.

 

Before joining GJU, Dr. Abuhaliema spent four years as Senior Scientist and Project Manager at Axxam GmbH in Konstanz, Germany. There he led preclinical drug discovery projects in oncology and rare diseases, including high-throughput screening campaigns and assay development for international pharmaceutical partners. He then served as Assistant Professor of Clinical Pharmacy and Therapeutics at Al-Ahliyya Amman University, where he supervised six MSc theses.

 

His research lies at the interface of drug discovery and precision medicine, with a focus on cancer. It covers targeted therapeutics, pharmacogenomics, drug repurposing, and gene- and RNA-based therapies, as well as pharmacoepidemiology and clinical outcomes research.